Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mouret

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|October 2, 2003
Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?P Chollet, S Amat, E Belembaogo, et al.
Annals of Surgical Oncology|May 2, 2009
Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patientsP Gimbergues, C Abrial, X Durando, et al.
Annals of Surgical Oncology|February 16, 2010
Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patientsP Gimbergues, M M Dauplat, X Durando, et al.
British Journal of Cancer|April 16, 2002
Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancerP Chollet, S Amat, H Cure, et al.
Cancer Epidemiology|March 16, 2025
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational studyJ Passildas, M J Paillard, L Uwer, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2015
[Salvage concomitant chemoradiation therapy for non-metastatic inflammatory breast cancer after chemotherapy failure]A Bellière-Calandry, C Benoît, S Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancerA Dezellus, P Barriere, M Campone, et al.
ESMO Open|November 29, 2024
Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohortF Giugliano, A Bertaut, J Blanc, et al.
Breast Cancer Research : BCR|December 3, 2025
<sup>18</sup>F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French studyM Chanchou, M A Mouret-Reynier, I Molnar, et al.
Breast (Edinburgh, Scotland)|August 21, 2024
Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-upA Dezellus, S Mirallie, F Leperlier, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|October 2, 2003
Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?P Chollet, S Amat, E Belembaogo, et al.
Annals of Surgical Oncology|May 2, 2009
Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patientsP Gimbergues, C Abrial, X Durando, et al.
Annals of Surgical Oncology|February 16, 2010
Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patientsP Gimbergues, M M Dauplat, X Durando, et al.
British Journal of Cancer|April 16, 2002
Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancerP Chollet, S Amat, H Cure, et al.
Cancer Epidemiology|March 16, 2025
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational studyJ Passildas, M J Paillard, L Uwer, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2015
[Salvage concomitant chemoradiation therapy for non-metastatic inflammatory breast cancer after chemotherapy failure]A Bellière-Calandry, C Benoît, S Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancerA Dezellus, P Barriere, M Campone, et al.
ESMO Open|November 29, 2024
Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohortF Giugliano, A Bertaut, J Blanc, et al.
Breast Cancer Research : BCR|December 3, 2025
<sup>18</sup>F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French studyM Chanchou, M A Mouret-Reynier, I Molnar, et al.
Breast (Edinburgh, Scotland)|August 21, 2024
Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-upA Dezellus, S Mirallie, F Leperlier, et al.
Pageof 6